What is Pulse Biosciences, Inc.'s other working capital?

Pulse Biosciences, Inc. (PLSE) reported other working capital of -$62K in Q1 2026.

What does other working capital mean?

Net change in working capital items not separately classified — a residual balancing item.

Pulse Biosciences, Inc. PLSE Other Working Capital

Other Working Capital at other companies

AbbottABT

$420M-3.7%

Boston ScientificBSX

$27M+486%

AtriCureATRC

$708K+43.0%

MedtronicMDT

$727M+20.0%

Merit Medical SystemsMMSI

-$314K-103%

ITG

Integer HoldingsITGR

-$716K+72.2%

Other financials

Income statement

See full

Revenue$401.0K—

Gross profit$31.0K—

Operating income-$19.2M-6.1%

Net income-$18.6M-10.6%

EPS (diluted)-$0.49-2.1%

Balance sheet

See full

Cash & equivalents$68.3M-42.7%

Total debt$7.2M-16.6%

Total equity$66.3M-44.0%

Total assets$81.6M-38.8%

Cash flow

See full

Operating cash flow-$14.6M-7.9%

CapEx$33.0K-26.7%

Free cash flow-$14.6M-7.8%

Valuation

See full

Market cap$1.77B+38.4%

Profitability

See full

Gross margin-4,067.5%—

Operating margin-10,392.1%—

Net margin-9,929%—

FCF margin-7,390%—

Returns & leverage

See full

Return on equity-80.7%+3.1pp

Debt / equity0.1×0.0×

Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s other working capital?: Pulse Biosciences, Inc. (PLSE) reported other working capital of -$62K in Q1 2026.
What does other working capital mean?: Net change in working capital items not separately classified — a residual balancing item.